Topics include the landscape of GLP-1 drug-device combination products in the US market, regulatory framing of acceptable UI differences, current CUHF study guidance and design fundamentals, case examples for pen injectors and autoinjectors, alternative CUHF approaches, device platform-based approaches for CA and HF data sharing, engineering considerations for generic GLP-1 injectors and drug-device interfaces, and CMC considerations for device evaluation
Just rinse with water to clear the acidity, then wait 30 minutes before brushing
Water Environ Res 90(10):11041170
Seek urgent care for severe allergic reactions, chest pain, shortness of breath, priapism lasting more than 4 hours, severe neurological symptoms, or rapidly worsening symptoms
Published Phase 2 data (Jastreboff et al., NEJM 2023, N=338) demonstrated that Retatrutide at 12mg achieved 24.2% mean body weight reduction at 48 weeks surpassing Tirzepatides 22.5% achieved in 24 additional weeks